Relation of angiographic and ultrasound assessment of plaque progression to clinical outcomes

American Journal of Cardiology

Volumn 81, Issue 8 A, 1998, Pages 69F-72F

  Weintraub, William S ^a   Dujovne, Carlos A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Kansas Foundation for Clinical Pharmacology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ANGIOPLASTY; ATHEROSCLEROTIC PLAQUE; COMPUTER ASSISTED DIAGNOSIS; CONFERENCE PAPER; CORONARY ARTERY DISEASE; FOLLOW UP; HUMAN; INCIDENCE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; ULTRASOUND;

EID: 0345563276     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00269-0     Document Type: Conference Paper

References (13)

1. Waters D, Craven TE, Lesperance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 1993;87:1067-1075.
2. Topol EJ, Nissen SE. The preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995;92:2333-2342.
3. Klein JL Treasure CB, Manoukian SV, Vogel RA, Beauman GJ, Fischman D, Savage MP, Boccuzzi SJ, Weintraub WS, for the Lovastatin Restenosis Trial Group. Performance standards and edge detection with computerized quantitative coronary arteriography. Am J Cardiol 1996;77:815-822.
4. Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, Chuang YC, Bucher TA, Sokolowicz LE, Leon MB. Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-1485.
5. Fuster V. Elucidation of the role of plaque instability and rupture in acute coronary events. Am J Cardiol 1995;76:24C-33C.
6. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophages and smooth muscle cell content. Br Heart J 1993;69:377-381.
7. Little W, Constantinescu M, Applegate R, Kutcher M, Burrows M, Kahl F, Santamore W. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-1166.
8. Brown BG, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan CK, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-1298.
9. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cachin-Hemphill L. Beneficial effects of colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987;257:3233-3240.
10. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD, Sawin HS, Campos CT, Hansen BJ, Tuna N, Karnegis JN, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Bissett JK, Weber FJ, Stevenson JW, Leon AS, Chalmers TC, and the POSCH Group. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias POSCH). N Engl J Med 1990;323:946-955.
11. Watts GF, Lewis B, Brunt JNH, Lewis ES, Coltart DJ, Smith LDR, Mann JI, Swan AV. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992;339:563-569.
12. Waters D, Higginson L, Gladstone P, Kimball B, Le May M, Boccuzzi SJ, Lesperance J. Effect of monotherapy with an HMG-CoA reductase inhibitor upon the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: the Canadian Coronary Atherosclerosis Intervention Trial (CCAIT). Circulation 1994;89:959-968.
13. Furberg CD, Adams HP Jr, Applegate WB, Byingron RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA, Young B, for the Asymptomatic Carotid Artery Progression Study (ACAPS). Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 1994;90:1679-1687.